Glucose Measurement: Confounding Issues in Setting Targets for Inpatient Management
Response to Dungan et al.
- John Mahoney, BA1 and
- John Ellison, MS2
- 1Department of Global Product Support, LifeScan, Milpitas, California
- 2Department of Clinical Research, LifeScan, Milpitas, California
- Address correspondence to John Mahoney, LifeScan, 1000 Gibraltar Dr., M/S 3I, Milpitas, CA 95035-6312. E-mail: jmahoney{at}lfsus.jnj.com
We thank Dungan et al. (1) for their recent review of the potential factors that can adversely affect inpatient glucose measurements. Their review is timely and provides a much-needed overview of an important and complex subject, especially now that hospitals are using point-of-care devices to monitor intensive insulin protocols.
However, we feel that the information listed in Table 1 of their study is potentially misleading. First, the presence …
